The Patent Finder
IP

Isis Pharmaceuticals, Inc.

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

8 patents currently held

98 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
11 more records may belong here and await a decision; they are not counted.

The next term ends in Jan 2027. from the record

Of the 98 now held by other companies, 80 name Ionis Pharmaceuticals Inc. as their current owner, and 18 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
3
Ending by 2030
Jan 2027
Next term end
7
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents fee due within 90 days all others Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank

Formerly held, still cited

Notable
Cited by 346 later US patents, top 1% of utility patents granted in 2011 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2028.
Ends Mar 2028 · High confidence
Also notable
Cited by 119 later US patents, top 5% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2028. A terminal disclaimer caps this term to an earlier patent's.
Ends Apr 2028 · Low confidence
Also notable
Cited by 146 later US patents, top 5% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2034. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Ends no later than May 2034 · Medium confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 23, 2026
    The maintenance fee for Modulation of Transthyretin Expression (US 9,061,044) comes due Dec 23, 2026. Unpaid by Jun 23, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 18, 2026

What they patent

The 5 largest of its 7 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 8 of 8

PatentTitleStatusExpiresConfidence
US 7,951,934Compositions and Their Uses Directed to Huntingtin
In force
 · High confidence
In forceHigh confidence
US 8,680,067Targeting Micrornas for the Treatment of Liver Cancer
In force
 · High confidence
In forceHigh confidence
US 9,717,750Compositions and Methods for Modulation of SMN2 Splicing in a Subject
In force
 · Medium confidence
In forceMedium confidence
US 9,061,044Modulation of Transthyretin Expression
In force
 · Low confidence
In forceLow confidence
US 9,359,608Modulation of Signal Transducer and Activator of Transcription 3 (STAT3) Expression
In force
 · High confidence
In forceHigh confidence
US 9,926,559Compositions and Methods for Modulation of SMN2 Splicing in a Subject
In force
 · High confidence
In forceHigh confidence
US 10,669,546Compositions for Modulating SOD-1 Expression
In force
 · High confidence
In forceHigh confidence
US 10,968,453Compositions for Modulating SOD-1 Expression
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 8: 98 patents in force now held by others · 280 patents ended · 3 applications pending · 677 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited